DiMeglio, L. A., Evans-Molina, C. & Oram, R. A. Type 1 diabetes. Lancet 391, 2449–2462 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Lam, C. J. et al. β-cell mass in type 1 diabetes: A decade of progress. Curr. Opin. Endocrinol. Diab Obes. 26, 19–27 (2019).

Google Scholar 

International Diabetes Federation. IDF Diabetes Atlas 11th ed. (International Diabetes Federation, 2023).

Al-Kazraj, N. H., Al-Shammaree, S. A. W. & Al-Janabi, J. M. Epidemiology of type 1 diabetes mellitus among children in Iraq: A systematic review and meta-analysis. Diab Res. Clin. Pract. 172, 108636 (2021).

Google Scholar 

Khan, M. A. et al. Epidemiology of type 1 diabetes - A systematic review of country-level data from the Middle East and North Africa region. Clin. Epidemiol. 12, 989–1007 (2020).

Google Scholar 

Robertson, C. C. et al. Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat. Genet. 53, 962–971 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacobsen, L. M. et al. Immune mechanisms and pathways targeted in type 1 diabetes. Curr. Diab Rep. 20, 1–11 (2020).

Google Scholar 

Atkinson, M. A., Campbell-Thompson, M., Kusmartseva, I. & Kaestner, K. H. Organization of the human pancreas in health and disease. Diabetologia 65, 932–942 (2022).

Google Scholar 

Chen, Y. G., Cabrera, S. M. & Dickson, B. M. Molecular profiles of islet inflammation associated with progression to type 1 diabetes. Diabetes 70, 1760–1772 (2021).

Google Scholar 

Coppieters, K. T. et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 209, 51–60 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zoka, A. et al. Altered immune regulation in type 1 diabetes. Clin. Dev. Immunol. 2019, 1–10 (2019).

Google Scholar 

Fatima, N. et al. Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type 1 diabetes: Correlation with age and glycemic condition in diabetic human subjects. PLoS One 15, e0228006 (2020).

Google Scholar 

Abdullah, M. et al. Role of inflammatory cytokines in pathogenesis of type 1 diabetes: A review of current evidence. Clin. Exp. Immunol. 205, 30–41 (2021).

Google Scholar 

Alnek, K. et al. Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes. PLoS One 15, e0233737 (2020).

Google Scholar 

Carlos, D. et al. The Th17 pathway in type 1 diabetes: Mechanisms and therapeutic perspectives. Front. Immunol. 12, 721955 (2021).

Google Scholar 

Mahmoud, F. et al. Elevated concentrations of interleukins IL-17 and IL-23 in type 1 diabetes mellitus: A study in patients from Kuwait. Immunol. Lett. 226, 22–29 (2020).

Google Scholar 

Zatterale, F. et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front. Physiol. 10, 1607 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Rigby, M. R. et al. Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Diab Endocrinol. 1, 284–294 (2013).

Article  CAS  Google Scholar 

Quattrin, T. et al. Golimumab and beta-cell function in youth with new-onset type 1 diabetes. N. Engl. J. Med. 383, 2007–2017 (2020).

Article  CAS  PubMed  Google Scholar 

Rigby, M. R. et al. Two-year follow-up from the T1GER study: Continued off-therapy metabolic improvements in children and young adults with new-onset T1D treated with golimumab and characterization of responders. Diab Care 46, 561–569 (2023).

Article  CAS  Google Scholar 

Moran, A. et al. Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381, 1905–1915 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hahn, M., Ghanbari, M. & van Meurs, J. B. The role of DNA methylation in the development of type 1 diabetes. Clin. Epigenetics 13, 1–15 (2021).

Google Scholar 

Li, Y. Y. et al. Role of gut microbiota in type 1 diabetes and its treatment. J. Diab Investig. 12, 1794–1806 (2021).

Google Scholar 

Abdulrazzaq, A. M., Al-Gazally, M. E. & Alkafaji, H. M. Assessment of serum IL-17 and IL-10 levels in children and adolescents with type 1 diabetes mellitus. Med. J. Babylon. 16, 136–140 (2019).

Google Scholar 

Ahmed, S. A., Raouf, M. & Al-Shammary, A. M. IL-17A, IL-21, and TGF-β levels in Iraqi patients with type 1 diabetes mellitus: Association with disease parameters. J. Diab Res. 2020, 3958456 (2020).

Google Scholar 

Ali, R. M., Al-Mayah, Q. S. & Jebur, M. S. Genetic variants in IL-6 and IL-10 genes and susceptibility to type 1 diabetes mellitus in Iraqi children. Meta Gene 26, 100784 (2020).

Google Scholar 

Al-Yasiri, I. K., Zghair, K. H. & Al-Sharifi, L. M. Interleukin-6 gene polymorphism is associated with increased risk of type 1 diabetes mellitus in Iraqi children. Gene Rep. 17, 100523 (2019).

Google Scholar 

American Diabetes Association Classification and diagnosis of diabetes: Standards of medical care in diabetes-2023. Diab Care 46, S19–S40 (2023).

Article  Google Scholar 

Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2^(-ΔΔCT) method. Methods 25, 402–408 (2001).

Article  CAS  PubMed  Google Scholar 

Bellini, S. et al. Immunometabolic modulation of immune cells in type 1 diabetes: Novel insights and therapeutic perspectives. Biomedicines 12, 395 (2024).

Google Scholar 

D’Agostino, S., Valentini, G. & Dolci, M. Exploring interleukin levels in type 1 diabetes and periodontitis: A review with a focus on childhood. Child. (Basel) 11, 238 (2024).

Google Scholar 

Skyler, J. S. et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 71, 698–707 (2022).

Google Scholar 

Al-Shuwaikh, A. M., Abdul-Hassan, I. A. & Al-Tu’ma, F. J. Association of interleukin-6 and interleukin-10 gene polymorphisms with type 1 diabetes mellitus in Iraqi children. Meta Gene 29, 100904 (2021).

Google Scholar 

Kumar, L., Gupta, A. & Kumar, N. Association of interleukin-10 (-1082A>G) gene polymorphism with the risk of type 1 diabetes in Asian population: A meta-analysis. Cytokine 124, 154569 (2019).

Google Scholar 

Zhang, S., Wang, Q., Zhao, H. & Peng, X. Influence of the interleukin-17A gene polymorphism on susceptibility to type 1 diabetes mellitus. Diab Res. Clin. Pract. 168, 108370 (2020).

Google Scholar 

Hassan, M. M. et al. Circulating CXCL10 and IL-17 in relation to insulin requirements in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 34, 101–107 (2021).

Google Scholar 

Katsarou, A. et al. Predictors of development of type 1 diabetes in children with islet autoimmunity: A population-based and registry study. Diab Care 45, 1327–1336 (2022).

Google Scholar 

Mubarak, A. et al. Association of cytokines gene polymorphisms with type 1 diabetes mellitus in Saudi children. PeerJ 8, e9358 (2020).

Google Scholar 

Fuhrman, C. A. et al. Quantitative profiling of immune cells in type 1 diabetes using mass cytometry. Diabetologia 64, 1599–1612 (2021).

Google Scholar 

Fathi, R. A. et al. Environmental pollution by depleted uranium in Iraq with special reference to Mosul and possible effects on cancer and birth defect rates. Med. Confl. Surviv. 29, 7–25 (2013).

Article  PubMed  Google Scholar